let-7i inhibits proliferation and migration of bladder cancer cells by targeting HMGA1

Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.

Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T, Ribal MJ, Van der Heijden AG, Sherif A. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65:778–92.

H v d M, Sengelov L, Roberts JT, et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol. 2005;23(21):4602–8.

Jewell JL, Flores F, Guan KL. Micro(RNA) managing by mTORC1. Mol Cell. 2015;57(4):575–6.

Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843.

You W, Zhang X, Ji M, et al. MiR-152-5p as a microRNA passenger strand special functions in human gastric cancer cells. Int J Biol Sci. 2018;14(6):644–53.

Rohan T, Ye K, Wang Y, Glass AG, Ginsberg M, Loudig O. MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer. PLoS One. 2018;13(2):e0191814.

Blanca A, Cheng L, Montironi R, et al. Mirna expression in bladder Cancer and their potential role in clinical practice. Curr Drug Metab. 2017;18(8):712.

Kim J, Yao F, Xiao Z, Sun Y, Ma L. MicroRNAs and metastasis: small RNAs play big roles. Cancer Metastasis Rev. 2018;37(1):5–15.

Akkafa F, Koyuncu İ, Temiz E, Dagli H, Dïlmec F, Akbas H. miRNA-mediated apoptosis activation through TMEM 48 inhibition in A549 cell line. Biochem Biophys Res Commun. 2018;503(1):323–9.

Chivukula RR, Shi G, Acharya A, et al. An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell. 2014;157(5):1104–16.

Guelfi G, Cochetti G, Stefanetti V, et al. Next generation sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research. Sci Rep. 2018;8(1):7111.

Lu Y, Liu P, Van den Bergh F, et al. Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer. Cancer Prev Res (Phila). 2012;5(2):248–59.

Arnoldo L, Sgarra R, Chiefari E, et al. A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin. Sci Rep. 2015;5:8552.

Conte A, Paladino S, Bianco G, et al. High mobility group A1 protein modulates autophagy in cancer cells. Cell Death Differ. 2017;24(11):1948–62.

Paz EA, LaFleur B, Gerner EW. Polyamines are oncometabolites that regulate the LIN28/let-7 pathway in colorectal cancer cells. Mol Carcinog. 2014;53(Suppl 1):E96–106.

Liu K, Zhang C, Li T, et al. Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1. Int J Oncol. 2015;46(6):2526–34.

Zhang X, Wu M, Chong QY, et al. Amplification of Hsa-miR-191/425 locus promotes breast Cancer proliferation and metastasis by targeting DICER1. Carcinogenesis. 2018:39(12):1506-16.

Eminaga O, Fries J, Neiß S, et al. The upregulation of hypoxia-related miRNA 210 in primary tumor of lymphogenic metastatic prostate cancer. Epigenomics. 2018:10(10):1347-59.

Karmakar S, Kaushik G, Nimmakayala R, Rachagani S, Ponnusamy MP, Batra SK. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention. Semin Cancer Biol. 2019:54:63-71.

Tvingsholm SA, Hansen MB, KKB C, et al. Let-7 microRNA controls invasion-promoting lysosomal changes via the oncogenic transcription factor myeloid zinc finger-1. Oncogenesis. 2018;7(2):14.

Song J, Wang L, Ma Q, et al. Let-7i-5p inhibits the proliferation and metastasis of colon cancer cells by targeting kallikrein-related peptidase 6. Oncol Rep. 2018:40(3):1459-66.

Ottley EC, Nicholson HD, Gold EJ. Activin a regulates microRNAs and gene expression in LNCaP cells. Prostate. 2016;76(11):951–63.

Kozinn SI, Harty NJ, Delong JM, et al. MicroRNA profile to predict gemcitabine resistance in bladder carcinoma cell lines. Genes Cancer. 2013;4(1–2):61–9.

Tian Y, Hao S, Ye M, et al. MicroRNAs let-7b/i suppress human glioma cell invasion and migration by targeting IKBKE directly. Biochem Biophys Res Commun. 2015;458(2):307–12.

Shi Y, Duan Z, Zhang X, Zhang X, Wang G, Li F. Down-regulation of the let-7i facilitates gastric cancer invasion and metastasis by targeting COL1A1. Protein Cell. 2019:10(2):143-8.

Sepe R, Piscuoglio S, Quintavalle C, et al. HMGA1 overexpression is associated with a particular subset of human breast carcinomas. J Clin Pathol. 2016;69(2):117–21.

Hillion J, Roy S, Heydarian M, et al. The high mobility group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives matrix Metalloproteinase-2 (MMP-2) in a subset of tumors. Gynecol Oncol. 2016;141(3):580–7.

Pegoraro S, Ros G, Piazza S, et al. HMGA1 promotes metastatic processes in basal-like breast cancer regulating EMT and stemness. Oncotarget. 2013;4(8):1293–308.

Lin Y, Chen H, Hu Z, Mao Y, Xu X, Zhu Y, Xu X, Wu J, Li S, Mao Q, Zheng X, Xie L. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. FEBS Lett. 2013;587:2467–73.

Cinkornpumin J, Roos M, Nguyen L, et al. A small molecule screen to identify regulators of let-7 targets. Sci Rep. 2017;7(1):15973.

Zhou WB, Zhong CN, Luo XP, et al. miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer. Biochem Biophys Res Commun. 2016;470(4):838–44.